Skip to main content
ResearchTreatments

Dr. Pennell on the Evolution of Targeting HER2 in Lung Cancer

By October 16, 2020March 2nd, 2021No Comments

*September 2020*

Nathan A. Pennell, MD, PhD, an associate professor in the Department of Medicine and director of the Lung Cancer Medical Oncology Program at the Taussig Cancer Institute of Cleveland Clinic, discusses the evolution of targeting HER2 in lung cancer. Watch the video.